Nanchang Biolight Meditech Co., Ltd. announced that it expects to receive CNY 20 million in funding from Guangdong Biolight Meditech Co., Ltd.
November 05, 2020
Share
Nanchang Biolight Meditech Co., Ltd. announced a private placement of CNY 20,000,000 in an equity round of funding on November 6, 2020. The transaction will include participation from returning investor, Guangdong Biolight Meditech Co., Ltd. (SZSE:300246). Post closing, investor will retain its 100% stake in the transaction. The registered capital will increase from CNY 30,000,000 to CNY 50,000,000. The transaction has been approved at the investor's 11th meeting of the 7th directorate and the 11th meeting of the 7th supervisory board and does not need the shareholders’ approval.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. 
